Effect of prolonged dexamethasone on oxygen-dependency in infants with chronic lung disease
- PMID: 10451887
Effect of prolonged dexamethasone on oxygen-dependency in infants with chronic lung disease
Abstract
To determine the effect of prolonged dexamethasone therapy on oxygen-dependency clinical phase of prematures with bronchopulmonary dysplasia, we examined a consecutive group of 27 infants (birth weight, < 1500 g and gestational age, < 32 weeks), who remained with a static or deteriorating oxygen-dependency after weaning from the respirator [pre-treatment FiO2, mean +/- SEM over three days (31 +/- 2)%, range (27-73)%]. Twenty five out of 27 infants were weaned from supplemental oxygen during the 42-day steroid treatment period, with a mean (+/- SEM) duration of oxygen supplementation of 16 +/- 4 days. The distribution of the ratios of successive post-treatment FiO2 values with respect to pre-treatment FiO2 shows, on average, a progressive reduction with time. The percentage of the FiO2 decrease is statistically significant at a level of 2 and 3 SD after 3 days and 7 days, respectively and the average FiO2 fall, as function of time, follows an exponential law. It follows that the time spent in oxygen for a single patient may be determined, accounting for the individual severity of pre-treatment FiO2.
Similar articles
-
Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.J Perinatol. 2009 Apr;29(4):297-304. doi: 10.1038/jp.2008.194. Epub 2008 Dec 4. J Perinatol. 2009. PMID: 19052552
-
[Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g].Klin Padiatr. 1994 Sep-Oct;206(5):372-6. doi: 10.1055/s-2008-1046630. Klin Padiatr. 1994. PMID: 7799612 German.
-
Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.Pediatr Pulmonol. 2004 Jul;38(1):55-63. doi: 10.1002/ppul.20037. Pediatr Pulmonol. 2004. PMID: 15170874 Clinical Trial.
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Bronchopulmonary dysplasia and corticosteroid therapy: a case review.Neonatal Netw. 1996 Sep;15(6):35-40. Neonatal Netw. 1996. PMID: 8932070 Review.